Tracheal Stents Market To Reach US$ 272 Million By 2033

The global tracheal stents market is worth US$ 126 million in 2023 and is expected to reach US$ 272 million by the end of 2033.

Laryngeal and tracheal stents are used to anchor a surgical reconstruction of the larynx or trachea or to prevent lumen collapse. A stent can be used to hold the cricoid plate after it has been split anteriorly or posteriorly, with or without the implantation of cartilage, to keep the complexity in an expanded configuration during the healing phase. Stenting is often utilized to stabilize the laryngeal structure for two to six weeks.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 -https://www.factmr.com/connectus/sample?flag=S&rep_id=8175?PS

One of the main factors driving the market revenue is the rising preference for minimally-invasive surgeries and the expanding use of endoscopic therapies. The development of innovative non-vascular stents is being fueled by growing public and private investments in research and development, which is encouraging their use for airway stenting. Furthermore, increasing investments in healthcare infrastructure across the globe are resulting in the development of modern, well-equipped healthcare facilities, which is further enhancing the tracheal stents market growth.

North America and Europe are currently dominating the sales of tracheal stents due to the presence of key market players in these regions, growing senior population, rising cases of respiratory-related disorders, and the presence of advanced healthcare facilities. The Asia Pacific market is predicted to expand at the fastest pace during the forecast period (2023-2033).

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Global demand for tracheal stents is expected to increase at a CAGR of 8% from 2023-2033.
• China's market is predicted to expand at a CAGR of 12% during the projected period.
• Sales of metal stents are expected to rise at a CAGR of 8.5% during the forecast period.
• Demand for plastic stents is predicted to expand at a CAGR of 7.5% during the next 10 years.

"Rapidly growing prevalence of lung cancer and chronic obstructive pulmonary diseases is augmenting the sales growth of tracheal stents," says a Fact.MR analyst.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐓𝐫𝐚𝐜𝐡𝐞𝐚𝐥 𝐒𝐭𝐞𝐧𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐁𝐲 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥 :

Metal
Plastic
Silicone

By Patient :

Adults
Pediatrics

By End User :

Hospitals
Ambulatory Surgical Centers

By Region :

North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8175?PS

𝐖𝐢𝐧𝐧𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲

Tracheal stent sales and market share are currently dominated by some of the leading companies. Smaller and mid-sized firms, on the other hand, are growing their market share by introducing new products at affordable prices by adopting new technologies. To grow their businesses and enter new markets, market participants for tracheal stents frequently use mergers and collaborations.

In February 2020, BIOTRONIK got CE Mark clearance for its Orsiro Mission drug-eluting stent or DES system. Comparing this technique to other types of modern stents now utilised in healthcare facilities, it claims to have a greater deliverability rate.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

• Bess Aktiengesellschaft (Bess AG)
• Boston Scientific Corporation
• Cook Group
• E. Benson Hood Laboratories, Inc.
• Efer Endoscopy
• Endo-Flex GmbH
• Merit Medical Systems, Inc.
• Micro-Tech (Nanjing) Co., Ltd.
• Novatech SA
• Standard Sci. Tech, Inc.
• Stening SRL
• Taewoong Medical Co., Ltd.

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact. MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.